Canada’s Drug Agency is pleased to announce the recipients of our 2024 Recognition Awards. These awards honour individuals who are pushing the science of health technology assessment (HTA) forward, mentoring the next generation of leaders, and helping to grow Canada’s reputation for excellence in the field.
This year marks the introduction of a new award that recognizes early-career professionals with the potential to become leaders in health economics. The award is named in honour of the late Dr. Murray Krahn, a beloved physician and giant in the field of economic evaluation and HTA.
Dr. Mina Tadrous is at the forefront of research that has led to meaningful change at both the policy and patient level. At the Ontario Drug Policy Research Network (ODPRN), he played a key role in implementing a novel framework for drug class reviews that enhanced standard HTA methods with patient and citizen perspectives and real-world evidence (RWE). This approach is driving formulary modernization in Ontario and elsewhere.
More News
Image
Bridging Research and Industry: GRIP 2025 highlights innovation and real-world impact
Over 200 attendees from academia, healthcare, and industry gathered last week for the 2025 GRIP symposium, celebrating the depth and diversity of graduate student research.
Read More
Image
Seven pharmacists recognized as APPE Preceptors of the Year
Preceptor of the Year Awards recognize excellence in teaching and mentorship.
Read More
Image
Stem Cell Network announces $33M to advance 36 regenerative medicine research projects and clinical trials
Assistant Professor Bowen Li has received funding to advance gene therapy research with a focus on cystic fibrosis and cardiac regeneration.
Read More